共 50 条
- [2] CHARACTERIZATION OF THE URINARY MICROBIOME IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E621 - E621
- [5] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
- [6] Variation in the commensal urinary microbiome is associated with response to Bacillus Calmette-Guerin (BCG) immunotherapy in early stage urothelial bladder cancer [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
- [9] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13